methyl 2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetate

We are methyl 2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetate CAS:258273-50-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: methyl 2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetate
CAS.NO:  258273-50-6
Synonyms:
methyl 2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetate

Molecular Formula: C18H18N2O2
Molecular Weight:294.34800

Physical and Chemical Properties:
Density: 1.161g/cm3
Boiling point: /
Melting point:/
Flash point:/
Refractive index: 1.599

Specification:
Appearance: Off-white or white crystalline solid
Purity:≥99%
Impurities: ≤0.2%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Zolpidem  CAS: 82626-48-0
Intermediates of Zolpidem tartrate  CAS:99294-93-6

methyl 2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetate


Related News: Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday.2-bromoheptanoato de etilo CAS:5333-88-0 Retrogenix’s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.10016-52-1 Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).1,2,3,4,5-pentafluorobenceno CAS:363-72-4 Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).In the TOP50 list of API export companies in 2017, the geographical clustering of advantageous companies is still obvious. For example, Huahai and Pluo in Zhejiang, CSPC of Hebei, Xinhua Pharmaceutical and Xinfa Pharmaceutical of Shandong rank well. Rank.

Related Products
Product Name
,3,4,6-Tetra-O-benzyl-D-gluconic acid-δ-lactone View Details
flucytosine View Details
(7-Azabenzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate View Details
2-chloro-4-isothiocyanatobenzonitrile manufacturer 2,3,6,7,10,11-Hexabromotriphenylene manufacturer ETHYL 5-NITROBENZOFURAN-2-CARBOXYLATE manufacturer (3R,4S,5R,6R)-2-(dichloromethyl)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-ol manufacturer 6-Bromo-2-chloropyridin-3-amine manufacturer